标题
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
作者
关键词
-
出版物
SCIENCE
Volume 373, Issue 6554, Pages 541-547
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2021-06-22
DOI
10.1126/science.abi4708
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
- (2021) Catherine Z. Chen et al. Frontiers in Pharmacology
- Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
- (2021) Kris M. White et al. SCIENCE
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
- (2020) Sangeun Jeon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SnapShot: Lysosomal Functions
- (2020) Lya K.K. Holland et al. CELL
- Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
- (2020) Oleg O. Glebov FEBS Journal
- The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target
- (2020) Mohamed Abu-Farha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Filovirus Antiviral Activity of Cationic Amphiphilic Drugs Is Associated with Lipophilicity and Ability To Induce Phospholipidosis
- (2020) Antonia P. Gunesch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
- (2020) Laura Riva et al. NATURE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- A molecular pore spans the double membrane of the coronavirus replication organelle
- (2020) Georg Wolff et al. SCIENCE
- Double-Membrane Vesicles as Platforms for Viral Replication
- (2020) Georg Wolff et al. TRENDS IN MICROBIOLOGY
- In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
- (2020) Franck Touret et al. Scientific Reports
- Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19
- (2020) Ulf Norinder et al. BIOMEDICINE & PHARMACOTHERAPY
- Syncytia formation by SARS‐CoV‐2 infected cells
- (2020) Julian Buchrieser et al. EMBO JOURNAL
- What Are the Odds of Finding a COVID-19 Drug from a Lab Repurposing Screen?
- (2020) Aled Edwards Journal of Chemical Information and Modeling
- Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo
- (2020) Stuart Weston et al. JOURNAL OF VIROLOGY
- Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
- (2020) David E. Gordon et al. SCIENCE
- Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
- (2020) Raveen Rathnasinghe et al. Emerging Microbes & Infections
- Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine
- (2020) Marion Plaze et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19
- (2020) Eric J. Lenze et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Zebra-like bodies in COVID-19: is phospholipidosis evidence of hydroxychloroquine induced acute kidney injury?
- (2020) Mohammad Obeidat et al. ULTRASTRUCTURAL PATHOLOGY
- Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
- (2020) Xia Xiao et al. Frontiers in Immunology
- Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody
- (2019) Laura M. Wingler et al. CELL
- Emerging mechanisms of drug-induced phospholipidosis
- (2019) Bernadette Breiden et al. BIOLOGICAL CHEMISTRY
- Antiviral activity of cationic amphiphilic drugs
- (2017) Cristiano Salata et al. Expert Review of Anti-Infective Therapy
- brms: An R Package for Bayesian Multilevel Models Using Stan
- (2017) Paul-Christian Bürkner Journal of Statistical Software
- Inhibition of cytosolic phospholipase A2α impairs an early step of coronavirus replication in cell culture
- (2017) Christin Müller et al. JOURNAL OF VIROLOGY
- Key cost drivers of pharmaceutical clinical trials in the United States
- (2016) Aylin Sertkaya et al. Clinical Trials
- Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC
- (2016) Aki Vehtari et al. STATISTICS AND COMPUTING
- Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists
- (2015) Han Cheng et al. JOURNAL OF VIROLOGY
- Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection
- (2015) Shanshan He et al. Science Translational Medicine
- A screen of approved drugs and molecular probes identifies therapeutics with anti–Ebola virus activity
- (2015) Lisa M. Johansen et al. Science Translational Medicine
- Evaluation of Ebola Virus Inhibitors for Drug Repurposing
- (2015) Peter B. Madrid et al. ACS Infectious Diseases
- Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
- (2014) Julie Dyall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Maintenance of luminal pH and protease activity in lysosomes/late endosomes by vacuolar ATPase in chlorpromazine-treated RAW264 cells accumulating phospholipids
- (2014) Ryohei Hamaguchi et al. CELL BIOLOGY AND TOXICOLOGY
- The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
- (2014) Gerrit Gehring et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Drug induced phospholipidosis: An acquired lysosomal storage disorder
- (2012) James A. Shayman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Identification of Drugs Inducing Phospholipidosis by Novel in vitro Data
- (2012) Markus Muehlbacher et al. ChemMedChem
- Ad5:Ad48 Hexon Hypervariable Region Substitutions Lead to Toxicity and Increased Inflammatory Responses Following Intravenous Delivery
- (2012) Lynda Coughlan et al. MOLECULAR THERAPY
- U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication
- (2011) Mee Kian Poh et al. ANTIVIRAL RESEARCH
- Predicting Phospholipidosis Using Machine Learning
- (2010) Robert Lowe et al. MOLECULAR PHARMACEUTICS
- Exploring the Importance of Piperazine N-Atoms for σ2Receptor Affinity and Activity in a Series of Analogs of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28)†
- (2009) Francesco Berardi et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vivo Retargeting of Adenovirus Type 5 to v 6 Integrin Results in Reduced Hepatotoxicity and Improved Tumor Uptake following Systemic Delivery
- (2009) L. Coughlan et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now